HR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
This resolution supports designating July 20, 2026, as "National Moon Landing Day" to honor the historic Apollo 11 mission and the ongoing Artemis program. The bill encourages Americans to celebrate the achievements of NASA astronauts, engineers, and scientists while honoring those who lost their lives during space exploration efforts. It also aims to inspire young people to pursue careers in STEM fields and promote public awareness of the economic and scientific benefits of human spaceflight.
The Medicare Advantage Supplemental Benefits Transparency Act of 2026 requires Medicare Advantage plans to submit detailed data on supplemental benefits to the federal government starting in 2029. This information will include specific details about what benefits are offered, eligibility rules, and how much each enrollee spends on these services. The Centers for Medicare & Medicaid Services will then make this de-identified data available to the public and researchers for analysis after a two-year delay. To support the implementation of these reporting requirements, the bill appropriates $12 million for fiscal year 2026.
The Modernizing Opioid Treatment Access Act 2.0 of 2026 allows specific addiction medicine specialists to prescribe methadone for opioid use disorder to be dispensed directly through pharmacies, rather than requiring patients to attend traditional treatment clinics. This change permits these qualified doctors to use telemedicine for patient care and requires that the methadone be in a liquid or dispersible tablet form. While the bill maintains existing clinic-based treatment options, it streamlines access by removing the need for pharmacies to obtain separate registrations to dispense the medication. The law also mandates that patients sign informed consent forms explaining how privacy rules differ between clinic and pharmacy settings, and it requires the Drug Enforcement Administration to report on the program's progress to Congress every year.
The Concealed Crime Prevention Act amends Washington, D.C. law to impose stricter prison sentences for individuals who wear ski masks or similar head coverings that conceal their identity while committing a crime. This provision specifically targets balaclavas and comparable gear while explicitly excluding religious headwear from the definition. Under the new rules, anyone found guilty of a misdemeanor while wearing such a mask faces a mandatory minimum of six months in prison, and those convicted of a felony face a mandatory minimum of two years. These additional sentences must be served consecutively to any other prison time given for the underlying offense and apply to crimes committed on or after the bill's enactment date.
HR 2913, the Ukraine Support Act, provides comprehensive U.S. support for Ukraine in response to Russia's invasion. The bill authorizes security assistance including lend-lease authority for military equipment, establishes a Ukraine Reconstruction Trust Fund for economic recovery, and imposes new sanctions targeting Russian financial institutions, oil companies, and government officials. It also includes provisions to counter Russian disinformation, support Radio Free Europe, and address the kidnapping of Ukrainian children. The legislation directly affects U.S. foreign policy, Ukraine's defense capabilities, and Russia's access to international financial systems. The act aims to strengthen Ukraine's sovereignty while holding Russia accountable for its actions.
The Save MEDICARE Act of 2026 aims to improve the Medicare Advantage program by starting in 2028 with several changes to how health plans are paid and monitored. It requires the government to exclude diagnoses from chart reviews when calculating payments to prevent plans from inflating costs based on questionable data. The bill also speeds up audits and appeals to ensure faster resolution of coding disputes and introduces a new penalty system to recover overpayments from plans. Additionally, the law allows states to enforce Medicare rules within their borders and bans financial incentives for doctors based on how they code patient records. Finally, it establishes a mechanism for the Department of Veterans Affairs to recover costs when Medicare Advantage plans cover care that should have been paid for by the VA.
This resolution honors the life and legacy of the late Senator Lindsey Olin Graham from South Carolina. It formally acknowledges his extensive career in the military, state government, and Congress, noting his service as a Senator and his roles as Chairman of the Judiciary and Budget committees. The Senate expresses its sorrow over his death and requests that this tribute be shared with the House of Representatives and Graham's family.
This resolution expresses the House of Representatives' support for maintaining equity, diversity, and inclusion in federally funded health research to improve scientific quality and patient outcomes. It opposes proposed administrative rules that would allow political appointees to override peer reviews, restrict international collaborations, and ban funding for studies on diversity and health disparities. The text highlights historical data showing that excluding women and people of color from research has led to medical gaps, such as inaccurate diagnostic tools for Black patients and delayed diagnoses for women with heart disease. Ultimately, the bill urges the administration to preserve the current science-based peer review system and remove barriers that prevent underserved communities from benefiting from medical advancements.
